Global Adult Non-Hodgkin Lymphoma Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Adult Non-Hodgkin Lymphoma Treatment market size was valued at USD 7820 million in 2022 and is forecast to a readjusted size of USD 13440 million by 2029 with a CAGR of 8.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Non-Hodgkin lymphoma (NHL) is an umbrella term for a group of independent diseases with strong heterogeneity
This report is a detailed and comprehensive analysis for global Adult Non-Hodgkin Lymphoma Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Adult Non-Hodgkin Lymphoma Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adult Non-Hodgkin Lymphoma Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adult Non-Hodgkin Lymphoma Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adult Non-Hodgkin Lymphoma Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adult Non-Hodgkin Lymphoma Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adult Non-Hodgkin Lymphoma Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Janssen Pharma, Genentech, Inc., CELGENE CORPORATION, Merck & Co.,Inc. and Kyowa Kirin Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Adult Non-Hodgkin Lymphoma Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Adult Non-Hodgkin Lymphoma Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adult Non-Hodgkin Lymphoma Treatment, with price, sales, revenue and global market share of Adult Non-Hodgkin Lymphoma Treatment from 2018 to 2023.
Chapter 3, the Adult Non-Hodgkin Lymphoma Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adult Non-Hodgkin Lymphoma Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adult Non-Hodgkin Lymphoma Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adult Non-Hodgkin Lymphoma Treatment.
Chapter 14 and 15, to describe Adult Non-Hodgkin Lymphoma Treatment sales channel, distributors, customers, research findings and conclusion.
Non-Hodgkin lymphoma (NHL) is an umbrella term for a group of independent diseases with strong heterogeneity
This report is a detailed and comprehensive analysis for global Adult Non-Hodgkin Lymphoma Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Adult Non-Hodgkin Lymphoma Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adult Non-Hodgkin Lymphoma Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adult Non-Hodgkin Lymphoma Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adult Non-Hodgkin Lymphoma Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adult Non-Hodgkin Lymphoma Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adult Non-Hodgkin Lymphoma Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Janssen Pharma, Genentech, Inc., CELGENE CORPORATION, Merck & Co.,Inc. and Kyowa Kirin Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Adult Non-Hodgkin Lymphoma Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- B Cell
- T Cell
- NK/T Cells
- Hospital
- Clinic
- Janssen Pharma
- Genentech, Inc.
- CELGENE CORPORATION
- Merck & Co.,Inc.
- Kyowa Kirin Co., Ltd.
- AbbVie Inc.
- Sanofi
- Takeda Pharmaceutical Company
- AstraZeneca
- Bayer AGNovartis AG
- Kite Pharma, Inc
- Spectrum Pharmaceuticals, Inc.
- Teva Pharmaceutical lndustries Ltd.
- Bristol Myers Squibb Company
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Adult Non-Hodgkin Lymphoma Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adult Non-Hodgkin Lymphoma Treatment, with price, sales, revenue and global market share of Adult Non-Hodgkin Lymphoma Treatment from 2018 to 2023.
Chapter 3, the Adult Non-Hodgkin Lymphoma Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adult Non-Hodgkin Lymphoma Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adult Non-Hodgkin Lymphoma Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adult Non-Hodgkin Lymphoma Treatment.
Chapter 14 and 15, to describe Adult Non-Hodgkin Lymphoma Treatment sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Adult Non-Hodgkin Lymphoma Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 B Cell
1.3.3 T Cell
1.3.4 NK/T Cells
1.4 Market Analysis by Application
1.4.1 Overview: Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Adult Non-Hodgkin Lymphoma Treatment Market Size & Forecast
1.5.1 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (2018-2029)
1.5.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Janssen Pharma
2.1.1 Janssen Pharma Details
2.1.2 Janssen Pharma Major Business
2.1.3 Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.1.4 Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Janssen Pharma Recent Developments/Updates
2.2 Genentech, Inc.
2.2.1 Genentech, Inc. Details
2.2.2 Genentech, Inc. Major Business
2.2.3 Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.2.4 Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Genentech, Inc. Recent Developments/Updates
2.3 CELGENE CORPORATION
2.3.1 CELGENE CORPORATION Details
2.3.2 CELGENE CORPORATION Major Business
2.3.3 CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.3.4 CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CELGENE CORPORATION Recent Developments/Updates
2.4 Merck & Co.,Inc.
2.4.1 Merck & Co.,Inc. Details
2.4.2 Merck & Co.,Inc. Major Business
2.4.3 Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.4.4 Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co.,Inc. Recent Developments/Updates
2.5 Kyowa Kirin Co., Ltd.
2.5.1 Kyowa Kirin Co., Ltd. Details
2.5.2 Kyowa Kirin Co., Ltd. Major Business
2.5.3 Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.5.4 Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kyowa Kirin Co., Ltd. Recent Developments/Updates
2.6 AbbVie Inc.
2.6.1 AbbVie Inc. Details
2.6.2 AbbVie Inc. Major Business
2.6.3 AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.6.4 AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AbbVie Inc. Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.7.4 Sanofi Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 Takeda Pharmaceutical Company
2.8.1 Takeda Pharmaceutical Company Details
2.8.2 Takeda Pharmaceutical Company Major Business
2.8.3 Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.8.4 Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.9.4 AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 Bayer AGNovartis AG
2.10.1 Bayer AGNovartis AG Details
2.10.2 Bayer AGNovartis AG Major Business
2.10.3 Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.10.4 Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bayer AGNovartis AG Recent Developments/Updates
2.11 Kite Pharma, Inc
2.11.1 Kite Pharma, Inc Details
2.11.2 Kite Pharma, Inc Major Business
2.11.3 Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.11.4 Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Kite Pharma, Inc Recent Developments/Updates
2.12 Spectrum Pharmaceuticals, Inc.
2.12.1 Spectrum Pharmaceuticals, Inc. Details
2.12.2 Spectrum Pharmaceuticals, Inc. Major Business
2.12.3 Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.12.4 Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
2.13 Teva Pharmaceutical lndustries Ltd.
2.13.1 Teva Pharmaceutical lndustries Ltd. Details
2.13.2 Teva Pharmaceutical lndustries Ltd. Major Business
2.13.3 Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.13.4 Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Teva Pharmaceutical lndustries Ltd. Recent Developments/Updates
2.14 Bristol Myers Squibb Company
2.14.1 Bristol Myers Squibb Company Details
2.14.2 Bristol Myers Squibb Company Major Business
2.14.3 Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.14.4 Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bristol Myers Squibb Company Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ADULT NON-HODGKIN LYMPHOMA TREATMENT BY MANUFACTURER
3.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adult Non-Hodgkin Lymphoma Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adult Non-Hodgkin Lymphoma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adult Non-Hodgkin Lymphoma Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Adult Non-Hodgkin Lymphoma Treatment Manufacturer Market Share in 2022
3.5 Adult Non-Hodgkin Lymphoma Treatment Market: Overall Company Footprint Analysis
3.5.1 Adult Non-Hodgkin Lymphoma Treatment Market: Region Footprint
3.5.2 Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Type Footprint
3.5.3 Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Adult Non-Hodgkin Lymphoma Treatment Market Size by Region
4.1.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Region (2018-2029)
4.2 North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.3 Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.5 South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
5.2 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type (2018-2029)
5.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
6.2 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application (2018-2029)
6.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
7.2 North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
7.3 North America Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
7.3.1 North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
8.3.1 Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Market Size by Region
9.3.1 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
10.2 South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
10.3 South America Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
10.3.1 South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
11.3.1 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Adult Non-Hodgkin Lymphoma Treatment Market Drivers
12.2 Adult Non-Hodgkin Lymphoma Treatment Market Restraints
12.3 Adult Non-Hodgkin Lymphoma Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Adult Non-Hodgkin Lymphoma Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adult Non-Hodgkin Lymphoma Treatment
13.3 Adult Non-Hodgkin Lymphoma Treatment Production Process
13.4 Adult Non-Hodgkin Lymphoma Treatment Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adult Non-Hodgkin Lymphoma Treatment Typical Distributors
14.3 Adult Non-Hodgkin Lymphoma Treatment Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Adult Non-Hodgkin Lymphoma Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 B Cell
1.3.3 T Cell
1.3.4 NK/T Cells
1.4 Market Analysis by Application
1.4.1 Overview: Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Adult Non-Hodgkin Lymphoma Treatment Market Size & Forecast
1.5.1 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (2018-2029)
1.5.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Janssen Pharma
2.1.1 Janssen Pharma Details
2.1.2 Janssen Pharma Major Business
2.1.3 Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.1.4 Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Janssen Pharma Recent Developments/Updates
2.2 Genentech, Inc.
2.2.1 Genentech, Inc. Details
2.2.2 Genentech, Inc. Major Business
2.2.3 Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.2.4 Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Genentech, Inc. Recent Developments/Updates
2.3 CELGENE CORPORATION
2.3.1 CELGENE CORPORATION Details
2.3.2 CELGENE CORPORATION Major Business
2.3.3 CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.3.4 CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CELGENE CORPORATION Recent Developments/Updates
2.4 Merck & Co.,Inc.
2.4.1 Merck & Co.,Inc. Details
2.4.2 Merck & Co.,Inc. Major Business
2.4.3 Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.4.4 Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co.,Inc. Recent Developments/Updates
2.5 Kyowa Kirin Co., Ltd.
2.5.1 Kyowa Kirin Co., Ltd. Details
2.5.2 Kyowa Kirin Co., Ltd. Major Business
2.5.3 Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.5.4 Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kyowa Kirin Co., Ltd. Recent Developments/Updates
2.6 AbbVie Inc.
2.6.1 AbbVie Inc. Details
2.6.2 AbbVie Inc. Major Business
2.6.3 AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.6.4 AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AbbVie Inc. Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.7.4 Sanofi Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 Takeda Pharmaceutical Company
2.8.1 Takeda Pharmaceutical Company Details
2.8.2 Takeda Pharmaceutical Company Major Business
2.8.3 Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.8.4 Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.9.4 AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 Bayer AGNovartis AG
2.10.1 Bayer AGNovartis AG Details
2.10.2 Bayer AGNovartis AG Major Business
2.10.3 Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.10.4 Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bayer AGNovartis AG Recent Developments/Updates
2.11 Kite Pharma, Inc
2.11.1 Kite Pharma, Inc Details
2.11.2 Kite Pharma, Inc Major Business
2.11.3 Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.11.4 Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Kite Pharma, Inc Recent Developments/Updates
2.12 Spectrum Pharmaceuticals, Inc.
2.12.1 Spectrum Pharmaceuticals, Inc. Details
2.12.2 Spectrum Pharmaceuticals, Inc. Major Business
2.12.3 Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.12.4 Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
2.13 Teva Pharmaceutical lndustries Ltd.
2.13.1 Teva Pharmaceutical lndustries Ltd. Details
2.13.2 Teva Pharmaceutical lndustries Ltd. Major Business
2.13.3 Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.13.4 Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Teva Pharmaceutical lndustries Ltd. Recent Developments/Updates
2.14 Bristol Myers Squibb Company
2.14.1 Bristol Myers Squibb Company Details
2.14.2 Bristol Myers Squibb Company Major Business
2.14.3 Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
2.14.4 Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bristol Myers Squibb Company Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ADULT NON-HODGKIN LYMPHOMA TREATMENT BY MANUFACTURER
3.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adult Non-Hodgkin Lymphoma Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adult Non-Hodgkin Lymphoma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adult Non-Hodgkin Lymphoma Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Adult Non-Hodgkin Lymphoma Treatment Manufacturer Market Share in 2022
3.5 Adult Non-Hodgkin Lymphoma Treatment Market: Overall Company Footprint Analysis
3.5.1 Adult Non-Hodgkin Lymphoma Treatment Market: Region Footprint
3.5.2 Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Type Footprint
3.5.3 Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Adult Non-Hodgkin Lymphoma Treatment Market Size by Region
4.1.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Region (2018-2029)
4.2 North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.3 Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.5 South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
5.2 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type (2018-2029)
5.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
6.2 Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application (2018-2029)
6.3 Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
7.2 North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
7.3 North America Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
7.3.1 North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
8.3.1 Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Market Size by Region
9.3.1 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
10.2 South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
10.3 South America Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
10.3.1 South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Market Size by Country
11.3.1 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Adult Non-Hodgkin Lymphoma Treatment Market Drivers
12.2 Adult Non-Hodgkin Lymphoma Treatment Market Restraints
12.3 Adult Non-Hodgkin Lymphoma Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Adult Non-Hodgkin Lymphoma Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adult Non-Hodgkin Lymphoma Treatment
13.3 Adult Non-Hodgkin Lymphoma Treatment Production Process
13.4 Adult Non-Hodgkin Lymphoma Treatment Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adult Non-Hodgkin Lymphoma Treatment Typical Distributors
14.3 Adult Non-Hodgkin Lymphoma Treatment Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Janssen Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Pharma Major Business
Table 5. Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 6. Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Janssen Pharma Recent Developments/Updates
Table 8. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Genentech, Inc. Major Business
Table 10. Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 11. Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Genentech, Inc. Recent Developments/Updates
Table 13. CELGENE CORPORATION Basic Information, Manufacturing Base and Competitors
Table 14. CELGENE CORPORATION Major Business
Table 15. CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 16. CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CELGENE CORPORATION Recent Developments/Updates
Table 18. Merck & Co.,Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co.,Inc. Major Business
Table 20. Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 21. Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck & Co.,Inc. Recent Developments/Updates
Table 23. Kyowa Kirin Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Kyowa Kirin Co., Ltd. Major Business
Table 25. Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 26. Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Kyowa Kirin Co., Ltd. Recent Developments/Updates
Table 28. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 29. AbbVie Inc. Major Business
Table 30. AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 31. AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AbbVie Inc. Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 36. Sanofi Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Company Major Business
Table 40. Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 41. Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Pharmaceutical Company Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 46. AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. Bayer AGNovartis AG Basic Information, Manufacturing Base and Competitors
Table 49. Bayer AGNovartis AG Major Business
Table 50. Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 51. Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bayer AGNovartis AG Recent Developments/Updates
Table 53. Kite Pharma, Inc Basic Information, Manufacturing Base and Competitors
Table 54. Kite Pharma, Inc Major Business
Table 55. Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 56. Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Kite Pharma, Inc Recent Developments/Updates
Table 58. Spectrum Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 59. Spectrum Pharmaceuticals, Inc. Major Business
Table 60. Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 61. Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
Table 63. Teva Pharmaceutical lndustries Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Teva Pharmaceutical lndustries Ltd. Major Business
Table 65. Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 66. Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Teva Pharmaceutical lndustries Ltd. Recent Developments/Updates
Table 68. Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 69. Bristol Myers Squibb Company Major Business
Table 70. Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 71. Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bristol Myers Squibb Company Recent Developments/Updates
Table 73. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Adult Non-Hodgkin Lymphoma Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Adult Non-Hodgkin Lymphoma Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Adult Non-Hodgkin Lymphoma Treatment Production Site of Key Manufacturer
Table 78. Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Type Footprint
Table 79. Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Application Footprint
Table 80. Adult Non-Hodgkin Lymphoma Treatment New Market Entrants and Barriers to Market Entry
Table 81. Adult Non-Hodgkin Lymphoma Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Adult Non-Hodgkin Lymphoma Treatment Raw Material
Table 141. Key Manufacturers of Adult Non-Hodgkin Lymphoma Treatment Raw Materials
Table 142. Adult Non-Hodgkin Lymphoma Treatment Typical Distributors
Table 143. Adult Non-Hodgkin Lymphoma Treatment Typical Customers
List of Figures
Figure 1. Adult Non-Hodgkin Lymphoma Treatment Picture
Figure 2. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Type in 2022
Figure 4. B Cell Examples
Figure 5. T Cell Examples
Figure 6. NK/T Cells Examples
Figure 7. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Adult Non-Hodgkin Lymphoma Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Adult Non-Hodgkin Lymphoma Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Adult Non-Hodgkin Lymphoma Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Adult Non-Hodgkin Lymphoma Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Adult Non-Hodgkin Lymphoma Treatment Market Drivers
Figure 74. Adult Non-Hodgkin Lymphoma Treatment Market Restraints
Figure 75. Adult Non-Hodgkin Lymphoma Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Adult Non-Hodgkin Lymphoma Treatment in 2022
Figure 78. Manufacturing Process Analysis of Adult Non-Hodgkin Lymphoma Treatment
Figure 79. Adult Non-Hodgkin Lymphoma Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Table 1. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Janssen Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Pharma Major Business
Table 5. Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 6. Janssen Pharma Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Janssen Pharma Recent Developments/Updates
Table 8. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Genentech, Inc. Major Business
Table 10. Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 11. Genentech, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Genentech, Inc. Recent Developments/Updates
Table 13. CELGENE CORPORATION Basic Information, Manufacturing Base and Competitors
Table 14. CELGENE CORPORATION Major Business
Table 15. CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 16. CELGENE CORPORATION Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CELGENE CORPORATION Recent Developments/Updates
Table 18. Merck & Co.,Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co.,Inc. Major Business
Table 20. Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 21. Merck & Co.,Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck & Co.,Inc. Recent Developments/Updates
Table 23. Kyowa Kirin Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Kyowa Kirin Co., Ltd. Major Business
Table 25. Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 26. Kyowa Kirin Co., Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Kyowa Kirin Co., Ltd. Recent Developments/Updates
Table 28. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 29. AbbVie Inc. Major Business
Table 30. AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 31. AbbVie Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AbbVie Inc. Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 36. Sanofi Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Company Major Business
Table 40. Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 41. Takeda Pharmaceutical Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Pharmaceutical Company Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 46. AstraZeneca Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. Bayer AGNovartis AG Basic Information, Manufacturing Base and Competitors
Table 49. Bayer AGNovartis AG Major Business
Table 50. Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 51. Bayer AGNovartis AG Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bayer AGNovartis AG Recent Developments/Updates
Table 53. Kite Pharma, Inc Basic Information, Manufacturing Base and Competitors
Table 54. Kite Pharma, Inc Major Business
Table 55. Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 56. Kite Pharma, Inc Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Kite Pharma, Inc Recent Developments/Updates
Table 58. Spectrum Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 59. Spectrum Pharmaceuticals, Inc. Major Business
Table 60. Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 61. Spectrum Pharmaceuticals, Inc. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Spectrum Pharmaceuticals, Inc. Recent Developments/Updates
Table 63. Teva Pharmaceutical lndustries Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Teva Pharmaceutical lndustries Ltd. Major Business
Table 65. Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 66. Teva Pharmaceutical lndustries Ltd. Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Teva Pharmaceutical lndustries Ltd. Recent Developments/Updates
Table 68. Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 69. Bristol Myers Squibb Company Major Business
Table 70. Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Product and Services
Table 71. Bristol Myers Squibb Company Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bristol Myers Squibb Company Recent Developments/Updates
Table 73. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Adult Non-Hodgkin Lymphoma Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Adult Non-Hodgkin Lymphoma Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Adult Non-Hodgkin Lymphoma Treatment Production Site of Key Manufacturer
Table 78. Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Type Footprint
Table 79. Adult Non-Hodgkin Lymphoma Treatment Market: Company Product Application Footprint
Table 80. Adult Non-Hodgkin Lymphoma Treatment New Market Entrants and Barriers to Market Entry
Table 81. Adult Non-Hodgkin Lymphoma Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Adult Non-Hodgkin Lymphoma Treatment Raw Material
Table 141. Key Manufacturers of Adult Non-Hodgkin Lymphoma Treatment Raw Materials
Table 142. Adult Non-Hodgkin Lymphoma Treatment Typical Distributors
Table 143. Adult Non-Hodgkin Lymphoma Treatment Typical Customers
List of Figures
Figure 1. Adult Non-Hodgkin Lymphoma Treatment Picture
Figure 2. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Type in 2022
Figure 4. B Cell Examples
Figure 5. T Cell Examples
Figure 6. NK/T Cells Examples
Figure 7. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Adult Non-Hodgkin Lymphoma Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Adult Non-Hodgkin Lymphoma Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Adult Non-Hodgkin Lymphoma Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Adult Non-Hodgkin Lymphoma Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Adult Non-Hodgkin Lymphoma Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Adult Non-Hodgkin Lymphoma Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Adult Non-Hodgkin Lymphoma Treatment Market Drivers
Figure 74. Adult Non-Hodgkin Lymphoma Treatment Market Restraints
Figure 75. Adult Non-Hodgkin Lymphoma Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Adult Non-Hodgkin Lymphoma Treatment in 2022
Figure 78. Manufacturing Process Analysis of Adult Non-Hodgkin Lymphoma Treatment
Figure 79. Adult Non-Hodgkin Lymphoma Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
